Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu | (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats:
- Alabama Drug Discovery Alliance
- Biochemistry and Molecular Genetics
- Biomatrix Engineering and Regenerative Medicine
- Cell biology
- Center for Biophysical Sciences and Engineering
- CCTS
- Center for Metabolic Bone Disease
- Microbiology
- Neurobiology
- Comprehensive Neuroscience Center
- Pathology, research shared with MS2
- Pharmacology and Toxicology
- Physiology and Biophysics
- UAB Research Foundation/IIE
- Research Administration
Responsibility for the safety, integrity and scientific validity of the trials fell to 12 experts of the COVID-19 Vaccine Data and Safety Monitoring Board, who now have taken the unusual step of publishing details of their review process.
COVID-19 vaccines were not developed overnight. Here are the astounding stories behind mRNA vaccines.
Researchers used a pig model of heart attacks, which more closely resembles the human heart in size and physiology, and thus has high clinical relevance to human disease.
A single intranasal dose provided sterilizing immunity — no detectable COVID-19 virus — in the lungs of vaccinated mice, in contrast to dense infection in lungs of unvaccinated mice.
ResBiotic Inc. will use the money to develop and commercialize groundbreaking probiotic formulations for lung health.
Knowledge of the specific flagellins that drive the pathogenic immune response in Crohn’s disease is a step toward a potential preventive treatment.
This 3D-printed anatomical finger model is a low-cost ultrasound training tool for procedural guidance in corticosteroid injections.
This transport system may be widespread across many Gram-positive bacteria that contain proteins in the WXG100 superfamily. Tuberculosis kills 1 million people each year.
Differences in DNA methylation correlated with differences in heart-failure outcomes, as measured by two-year mortality.
This study will aid the understanding of, and future research on, inflammatory bowel disease, which afflicts about 1.6 million Americans.